ALG2-CDG (CDG-Ii)
Don’t fight ALG2-CDG (CDG-Ii) alone.
Find your community on the free RareGuru App.Connect with other caregivers and patients with ALG2-CDG (CDG-Ii) and get the support you need.
The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.
Orpha Number: 79326
Definition
A form of congenital disorders of N-linked glycosylation characterized by iris coloboma, cataract, infantile spasms, developmental delay and abnormal coagulation factors. The disease is caused by loss-of-function mutations in the gene ALG2 (9q31.1). Transmission is autosomal recessive.
Visit the Orphanet disease page for more resources.
Source: GARD Last updated on 05-01-20
Symptoms
Symptoms and their Known Frequencies
80%-99% of people have these symptoms.
Click on a symptom to see definitions for associated terms.
| Cerebral hemorrhage |
| Plantar crease between first and second toes |
| Cataract |
| Increased T cell count |
| Nystagmus |
| Cognitive impairment |
| Iris coloboma |
| Seizures |
An unknown % of people have these symptoms.
Click on a symptom to see definitions for associated terms.
Colorado Springs, CO, 80937, Toll Free: (866) 295-7910 Email: info@cdgcare.com Url: http://cdgcare.com/ Name: Portugese Association for CDG and other Rare Metabolic Diseases APCDG-DMR Url: http://www.apcdg.com/
Connect with other users with ALG2-CDG (CDG-Ii) on the RareGuru app
Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!
